GTS Venture Capital
Venture capitalLos Angeles · Pre-Seed–Series A
Investment thesis
GTS Venture Capital is an early-stage venture capital fund based in Los Angeles that focuses on fintech investments.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does GTS Venture Capital invest at?
- GTS Venture Capital invests at the Pre-Seed, Seed, Series A stages.
- What sectors does GTS Venture Capital focus on?
- GTS Venture Capital focuses on Fintech.
- Where is GTS Venture Capital located?
- GTS Venture Capital is headquartered in Los Angeles, US.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Flybridge is an early-stage venture capital fund based on the East Coast that invests in AI-driven companies across infrastructure, agentic business applications, and native AI applications. The firm manages over $1 billion in assets and operates from offices in New York City and Boston.
Tennr streamlines patient flow in healthcare by automating referral management, insurance verification, clinical context aggregation, and appointment scheduling. The platform processes referrals and intake documentation for approximately 10% of Americans annually.